Korro Bio, Inc.

NASDAQ:KRRO

Biotechnology

Healthcare
$12.44 +15.88%

+$1.76 today

Market cap
$170.75M
Beta
2.10
P/E (TTM)
-1.3
EPS (TTM)
-$9.79
52W Low $5.20High $55.89

Volume 0.16M

Average 0.15M

Balance Sheet

Inspect the capital base behind the business.

Assets

$113.51M

FY 2025 · Annual

-49.8% YoY

Liabilities

$62.07M

FY 2025 · Annual

-5.7% YoY

Equity

$51.44M

FY 2025 · Annual

-67.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents79.64M36.94M166.15M55.64M21.82M
Short-term Investments51.07M18.92M070.45M53.33M
Net Receivables144K001.7M969K
Inventory00000
Other Current Assets1.04M(376K)3.56M3.74M6.25M
Total Current Assets134.75M57.08M172.73M131.53M82.37M
Property, Plant & Equipment (Net)36.87M11.89M42.82M51.55M16.22M
Goodwill00000
Intangible Assets00000
Long-term Investments13.42M4.54M3.41M36.96M12.44M
Tax Assets00002.2M
Other Non-current Assets320K228K2.71M6.2M270K
Total Non-current Assets50.61M16.66M48.94M94.71M31.13M
Total Assets185.36M73.74M221.66M226.24M113.51M
Account Payables2.75M2.61M7.28M3.99M1.65M
Short-term Debt2.58M2.92M000
Tax Payables00000
Deferred Revenue0003.51M7.84M
Other Current Liabilities1.73M551K395K4.05M(3.72M)
Total Current Liabilities11.43M8.7M19.48M14.96M11.94M
Long-term Debt14.17M163.86M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0005.91M7.84M
Other Non-current Liabilities87K163.86M1.05M1.47M1.48M
Total Non-current Liabilities43.11M164.07M32.27M50.87M50.13M
Total Liabilities54.53M172.77M51.75M65.83M62.07M
Common Stock35K08K9K9K
Retained Earnings(180.09M)(101.83M)(183.01M)(266.59M)(383.85M)
Accumulated OCI(62K)(5K)(0)268K212K
Other Stockholders Equity00000
Minority Interest00000
Total Equity130.82M(99.03M)169.91M160.42M51.44M
Total Debt45.6M166.99M33.21M44.77M43.49M
Net Debt(34.04M)130.06M(132.94M)(10.88M)21.66M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$61.7M
Short-term Investments$52.3M
Other Current$6.2M
Total Current Assets$120.2M
PP&E (Net)$15.6M
Long-term Investments$45.5M
Other Non-current$2.3M
Total Non-current Assets$63.5M
Total Assets$183.6M

Analysis

Selected assets total $183.6M for Latest. The largest visible component is Cash & Equivalents at $61.7M, about 33.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
SC 13GSC 13G filingNov 12, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 27, 2026

How much cash does KRRO have?

Korro Bio, Inc. (KRRO) reported $21.82M in cash and equivalents in fiscal 2025.

How much debt does KRRO carry?

Korro Bio, Inc. (KRRO) reported $43.49M of total debt, with net debt of $21.66M.